LOGIN  |  REGISTER
Terns Pharmaceuticals
Recursion

Teladoc Health Adds Workplace Safety Capability to its AI-Enabled Clarity™ Monitoring Solution for Hospitals and Health Systems

October 14, 2025 | Last Trade: US$7.59 0.19 -2.44
  • New capability aims to address the growing threat of workplace violence in healthcare settings, building on the company’s suite of AI-enabled solutions that leverage purpose-built technology to transform care

NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the launch of a new offering to help hospitals and health systems address workplace violence. This is the latest innovation within Teladoc Health's Clarity™ monitoring solution, which includes AI-enabled software, hardware and services that empower care teams to monitor care settings and quickly direct the right resources. The solution serves multiple use cases including virtual sitting and now virtual workplace safety intervention.

Workplace violence is a growing challenge facing hospitals. A recent survey found more than 80% of nurses have experienced workplace violence, and nearly half say violence has increased in recent years. According to the latest data from the Bureau of Labor Statistics, healthcare workers are five times more likely to experience workplace violence, compared to employees in other industries. Additionally, workplace and community violence costs hospitals more than $18 billion annually, according to a recent report from the American Hospital Association.

The new capability uses video and audio clues to analyze facial expressions, sense threatening gestures, and detect aggressive language. As an incident is escalating, the solution will provide intelligent, timely notifications to the appropriate care teams and staff to enable early intervention. It will actively identify specific safety risks, such as a person aggressively stepping into a nurse’s space or tampering with medical equipment.

“Healthcare workplace violence is a persistent and growing threat impacting care team safety, patient wellbeing, and health system operations,” said Andy Puterbaugh, President, Hospital and Health Systems at Teladoc Health. “While traditional tools are often reactive—relying on human vigilance or panic buttons—our new workforce safety capability is purpose-built to transform insights into action, using AI to empower early intervention and improve the safety of everyone in the care setting.”

The solution will be implemented with select hospitals and health systems in Q1 2026 as part of Teladoc Health’s partner development program.

For more information about Teladoc Health’s integrated virtual care solutions for hospitals and health systems, click here.

About Teladoc Health

Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.

Media
Lou Serio
This email address is being protected from spambots. You need JavaScript enabled to view it.
202-569-9715

Assertio

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page